Collaboration to advance patient care, support and education
AstraZeneca will support in conducting workshops and talks, and drive programmes to promote early detection and prevention.
Biopharmaceutical company AstraZeneca Singapore has signed a Memorandum of Understanding (MOU) with non-profit 365 Cancer Prevention Society (365CPS) to collaborate on programmes and campaigns that improve awareness, provide holistic support, and encourage early detection and prevention of cancer.
As part of the collaboration, AstraZeneca will be supporting 365CPS in conducting workshops and talks to raise awareness for lung cancer, to close existing knowledge gaps in diagnosis and identification of lung cancer, while giving patients a voice through collaborative initiatives to be heard. More details will be shared at a later date.
In addition, the collaboration involves driving programmes to promote early detection and prevention of other cancer types, which are crucial in improving health outcomes. This will include fundraising support for 365CPS’ ongoing #My1stMammo2022 and #My1stColonoscopy campaigns. The campaigns enable access to cancer screening for low-income individuals with a family history of cancer by providing fully sponsored mammograms and colonoscopy screenings, and fast-tracked pre- and post-screening consultations with a doctor. Both parties will provide support to patients from lower-income families to reduce the financial burden of cancer care.
365CPS’ initiatives for cancer patients include care and support programmes, counselling and wellness services, health and nutrition education and other activities to promote healthy lifestyles such as lymphatic exercise programmes. 365CPS has also set up social service centres to serve the needs of cancer fighters and to support their family members with practical solutions daily. Its centres are located at Ang Mo Kio, Bukit Panjang, Clementi, and Tampines.